domingo, 15 de abril de 2018

Cancer Information Highlights, April 11, 2018

Cancer Information Highlights, April 11, 2018
National Cancer Institute

Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
New from NCI
Infographic—Genetic Changes and Cancer
Genes contain information to make proteins, and proteins control many important functions like cell growth.  Our new infographic shows some genetic changes that can lead to cancer.
Can an Interactive App Improve Colorectal Cancer Screening Rates?
man looking at tablet Colon and rectal cancer screening reduces deaths from the disease, yet about one-third of Americans aren’t up to date with screening. Learn what happened when people waiting for routine checkups used an app that allowed them to order their own screening test.
Cancer Immunotherapy Drug Targets Two Proteins that Block Immune Response

Could the hybrid molecule called a Y-trap be more effective than an immune checkpoint inhibitor alone, without increasing side effects?
Higher Risk of Heart Failure Seen in Some Patients Treated for Cancer

Heart failure is a problem in which weakened or damaged heart muscles are unable to effectively pump blood to the rest of the body. Read about research that shows which cancer patients may be at risk for developing this problem.
Early Trial Results Show Promise for Patients with Rare Sarcomas

Early results from an NCI-funded randomized clinical trial for patients with desmoid tumors or aggressive fibromatosis show that a targeted therapy improved the length of time they lived before their disease got worse.
PDQ Summary Updates
Childhood Non-Hodgkin Lymphoma (NHL) Treatment

We’ve updated our PDQ summary on childhood NHL with treatment options for mucosa-associated lymphoid tissue (MALT) lymphoma, which is a type of NHL.
Cognitive Impairment in Adults with Cancer

We’ve added a new PDQ summary on cognitive impairment that occurs in adults treated for cancer that is not in the central nervous system.
Treatment of Unusual Cancers of Childhood

We’ve revised our PDQ summary on unusual childhood cancers with updated sections on radiation therapy, hormone therapy, and immunotherapy. Treatment options for neuroendocrine tumors and melanoma in children have also been updated.
Drug Information Updates
Brentuximab for Hodgkin Lymphoma

The Food and Drug Administration (FDA)-approved indications for brentuximab vedotin (Adcetris) have been expanded to include treatment of adults with previously untreated stage III or stage IV Hodgkin lymphoma.
Nilotinib Use in Leukemia

We’ve updated our nilotinib drug information summary with a newly approved FDA indication. Nilotinib (Tasigna) is now approved for use in adults and children aged one year and older to treat certain types of chronic myelogenous leukemia that is Philadelphia chromosome positive.
Also of Interest
NCI Contact Center

The NCI Contact Center provides accurate, up-to-date, and reliable cancer information that is easy to understand. Trained information specialists provide personalized responses to a range of cancer questions, including help finding clinical trials and quitting smoking.
Testicular Cancer

Testicular cancer is the most common cancer in men 15 to 34 years old. Visit the Testicular Cancer page to learn about the types of testicular cancer, symptoms, and treatment.
Chemicals in Meat Cooked at High Temperatures and Cancer Risk

Chemicals can form on the surface of meats when they are cooked at high temperatures. Learn about these chemicals, how they are formed, and what is known about how they affect cancer risk.

No hay comentarios:

Publicar un comentario